908 Devices Inc. (NASDAQ:MASS) Shares Bought by Barclays PLC

Barclays PLC grew its stake in 908 Devices Inc. (NASDAQ:MASS) by 452.7% during the 3rd quarter, Holdings Channel reports. The fund owned 46,214 shares of the company’s stock after acquiring an additional 37,853 shares during the period. Barclays PLC’s holdings in 908 Devices were worth $160,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. SG Americas Securities LLC acquired a new position in 908 Devices in the 3rd quarter valued at about $36,000. Drive Wealth Management LLC purchased a new stake in shares of 908 Devices during the third quarter worth about $50,000. Townsquare Capital LLC purchased a new stake in shares of 908 Devices during the third quarter worth about $50,000. 49 Wealth Management LLC raised its position in shares of 908 Devices by 16.2% in the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after buying an additional 4,343 shares during the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of 908 Devices by 18.6% during the second quarter. American Century Companies Inc. now owns 33,718 shares of the company’s stock valued at $174,000 after buying an additional 5,295 shares during the period. Institutional investors and hedge funds own 88.06% of the company’s stock.

Wall Street Analysts Forecast Growth

MASS has been the subject of several recent analyst reports. Leerink Partnrs cut shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Stifel Nicolaus lowered their price objective on 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Finally, Leerink Partners reiterated a “market perform” rating and issued a $4.00 target price (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th.

908 Devices Stock Performance

908 Devices stock opened at $2.13 on Wednesday. 908 Devices Inc. has a 1 year low of $1.81 and a 1 year high of $9.10. The firm has a 50 day moving average price of $2.54 and a 200 day moving average price of $3.64. The company has a market cap of $74.17 million, a price-to-earnings ratio of -1.20 and a beta of 0.96.

908 Devices Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.